Effect of Cannasen Nasal spray Night in Sleep

Phase 4

• Conditions: Health Condition 1: F510- Insomnia not due to a substance orknown physiological condition

• Registration Number: CTRI/2023/02/049401
• Lead Sponsor: Cannordic A/S

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 6 February 2023

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. Patient from 18 to 65 years of age.

2. Patient with the history of seasonal pollen allergy.

3. If female with childbearing potential, must be willing to practice an acceptable form of birth control for the duration of the study.

4. Patient that are able to give written informed consent in a manner approved by the institutional ethics committee and comply with the requirements of the study.

5. Patient willing to avoid participation in any other interventional clinical trial for the duration of the study.

Exclusion Criteria

1. Females that are pregnant, breast feeding, or planning to get pregnant during the study.

2. Patient that have participated in any other interventional clinical trial in the previous 30 days.

3. Patient with known sensitivity to any of the constituents of the investigational product.

4. Patient that are taking applying other product.

Study & Design

• Study Type: PMS
• Study Design: Not specified